We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Zacks Value Investor Highlights: Occidental, Anadarko, Avid, SYNNEX and j2 Global
Read MoreHide Full Article
For Immediate Release
Chicago, IL – May 3, 2019 – Zacks Value Investor is a podcast hosted weekly by Zacks Stock Strategist Tracey Ryniec. Every week, Tracey will be joined by guests to discuss the hottest investing topics in stocks, bonds and ETFs and how it impacts your life. To listen to the podcast, click here: (https://www.zacks.com/stock/news/407888/3-tips-for-building-a-buffettbeating-portfolio)
3 Tips for Beating a Buffett-Beating Portfolio
Welcome to Episode #139 of the Value Investor Podcast.
Every week, Tracey Ryniec, the editor of Zacks Value Investor portfolio, shares some of her top value investing tips and stock picks.
This week is the Berkshire Hathaway annual meeting in Omaha.
Usually, it’s a lovefest between Warren Buffett and the thousands of shareholder-fans but Barron’s recently pointed out that Berkshire’s stock (BRK.B - Free Report) has been under-performing the S&P 500 for the last 5, 10 and 15 years.
Berkshire is also sitting on $110 billion in cash, which isn’t doing much for the stock either.
Just this week, it was revealed that Berkshire had pledged $10 billion in an investment for Occidental (OXY - Free Report) to buy Anadarko , which is now the subject of a hostile bid with Chevron.
But the $10 billion is a drop in the cash bucket. What will they do with the other $100 billion?
All value investors are struggling in a market where growth stocks are king, but there are ways value investors can do better than Warren Buffett and his investing lieutenants.
3 Tips for Building a Better Portfolio
1. Think Small
Berkshire Hathaway is too big now. Buffett has billions to invest. He can’t mess around with a bunch of small cap companies.
But you can.
Avid Technology is the platform that powers film, television and music. It has a market cap of just $319 million. It’s cheap, with a forward P/E of only 11.3.
2. Think Technology
Warren Buffett has mostly eschewed technology companies, with IBM and Apple being the exceptions.
But the rest of us shouldn’t.
There are plenty of technology stocks that are also values right now.
SYNNEX (SNX - Free Report) is one of those. This technology services company has a price-to-sales ratio of just 0.3.
Shareholders also get a dividend, currently yielding 1.5%.
3. Think Digital
Warren Buffett has been a big fan of newspapers in the past, mostly for their amazing advertising moat in the classified ads.
But the Internet destroyed that moat and replaced it with digital media using display advertising.
Now, subscriptions are king and j2 Global is trying to get in on the changing digital media landscape. It operates a bunch of sites, including AskMen, Geek.com and Offers.com along with Everyday Health.
It is still cheap, with a forward P/E of just 12.9.
What else should you know about building a Buffett-beating portfolio?
Listen to this week’s episode to find out.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.
Zacks.com is a property of Zacks Investment Research, Inc., which was formed in 1978. The later formation of the Zacks Rank, a proprietary stock picking system; continues to outperform the market by nearly a 3 to 1 margin. The best way to unlock the profitable stock recommendations and market insights of Zacks Investment Research is through our free daily email newsletter; Profit from the Pros. In short, it's your steady flow of Profitable ideas GUARANTEED to be worth your time! Click here for your free subscription to Profit from the Pros.
Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss.This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Zacks Value Investor Highlights: Occidental, Anadarko, Avid, SYNNEX and j2 Global
For Immediate Release
Chicago, IL – May 3, 2019 – Zacks Value Investor is a podcast hosted weekly by Zacks Stock Strategist Tracey Ryniec. Every week, Tracey will be joined by guests to discuss the hottest investing topics in stocks, bonds and ETFs and how it impacts your life. To listen to the podcast, click here: (https://www.zacks.com/stock/news/407888/3-tips-for-building-a-buffettbeating-portfolio)
3 Tips for Beating a Buffett-Beating Portfolio
Welcome to Episode #139 of the Value Investor Podcast.
Every week, Tracey Ryniec, the editor of Zacks Value Investor portfolio, shares some of her top value investing tips and stock picks.
This week is the Berkshire Hathaway annual meeting in Omaha.
Usually, it’s a lovefest between Warren Buffett and the thousands of shareholder-fans but Barron’s recently pointed out that Berkshire’s stock (BRK.B - Free Report) has been under-performing the S&P 500 for the last 5, 10 and 15 years.
Berkshire is also sitting on $110 billion in cash, which isn’t doing much for the stock either.
Just this week, it was revealed that Berkshire had pledged $10 billion in an investment for Occidental (OXY - Free Report) to buy Anadarko , which is now the subject of a hostile bid with Chevron.
But the $10 billion is a drop in the cash bucket. What will they do with the other $100 billion?
All value investors are struggling in a market where growth stocks are king, but there are ways value investors can do better than Warren Buffett and his investing lieutenants.
3 Tips for Building a Better Portfolio
1. Think Small
Berkshire Hathaway is too big now. Buffett has billions to invest. He can’t mess around with a bunch of small cap companies.
But you can.
Avid Technology is the platform that powers film, television and music. It has a market cap of just $319 million. It’s cheap, with a forward P/E of only 11.3.
2. Think Technology
Warren Buffett has mostly eschewed technology companies, with IBM and Apple being the exceptions.
But the rest of us shouldn’t.
There are plenty of technology stocks that are also values right now.
SYNNEX (SNX - Free Report) is one of those. This technology services company has a price-to-sales ratio of just 0.3.
Shareholders also get a dividend, currently yielding 1.5%.
3. Think Digital
Warren Buffett has been a big fan of newspapers in the past, mostly for their amazing advertising moat in the classified ads.
But the Internet destroyed that moat and replaced it with digital media using display advertising.
Now, subscriptions are king and j2 Global is trying to get in on the changing digital media landscape. It operates a bunch of sites, including AskMen, Geek.com and Offers.com along with Everyday Health.
It is still cheap, with a forward P/E of just 12.9.
What else should you know about building a Buffett-beating portfolio?
Listen to this week’s episode to find out.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>
Tracey Ryniec is the Value Stock Strategist for Zacks.com. She is also the Editor of the Insider Trader and Value Investor services. You can follow her on twitter at @TraceyRyniec and she also hosts the Zacks Market Edge Podcast on iTunes.
About Zacks
Zacks.com is a property of Zacks Investment Research, Inc., which was formed in 1978. The later formation of the Zacks Rank, a proprietary stock picking system; continues to outperform the market by nearly a 3 to 1 margin. The best way to unlock the profitable stock recommendations and market insights of Zacks Investment Research is through our free daily email newsletter; Profit from the Pros. In short, it's your steady flow of Profitable ideas GUARANTEED to be worth your time! Click here for your free subscription to Profit from the Pros.
Follow us on Twitter: https://twitter.com/zacksresearch
Join us on Facebook: https://www.facebook.com/home.php#/pages/Zacks-Investment-Research/57553657748?ref=ts
Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.
Media Contact
Zacks Investment Research
800-767-3771 ext. 9339
support@zacks.com
https://www.zacks.com/performance
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss.This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.